BackgroundCheck.run
Search For

Ehab A Khalil, 57Highland Springs, VA

Ehab Khalil Phones & Addresses

Henrico, VA   

2149 S Kenmore Rd, Richmond, VA 23225    804-5622414   

2207 Mandalay Dr, Richmond, VA 23224    804-6754883   

North Chesterfield, VA   

Brooklyn, NY   

Milan, MI   

Work

Company: James River, Inc. Address: Richmond, VA Phones: 804-9373663 (Phone)

Languages

English • Arabic

Images

Mentions for Ehab A Khalil

Career records & work history

Real Estate Brokers

Ehab Khalil Photo 1

Ehab Khalil, Richmond VA - Agent

Specialties:
REO / Bank Owned
Short sales
Residential sales
First time home buyers
Distressed properties
Work:
James River, Inc.
Richmond, VA
804-9373663 (Phone)
Certifications:
SFR
e-PRO
Client type:
Home Buyers
Home Sellers
Property type:
Single Family Home
Condo/Townhome
Languages:
English
Arabic

Ehab Khalil resumes & CV records

Resumes

Ehab Khalil Photo 25

Licensed Realtor

Location:
Richmond, VA
Work:

Licensed Realtor
Ehab Khalil Photo 26

Owner And Dealer Operator

Location:
Richmond, VA
Industry:
Automotive
Work:
Savannah Motors
Owner and Dealer Operator
Education:
Long Island University
Ehab Khalil Photo 27

Ehab Khalil

Ehab Khalil Photo 28

Ehab Khalil

Ehab Khalil Photo 29

Ehab Khalil

Ehab Khalil Photo 30

Ehab Khalil

Publications & IP owners

Us Patents

Inhibitors Of Sorotonin N-Acetyltransferase

US Patent:
5990094, Nov 23, 1999
Filed:
Jan 27, 1998
Appl. No.:
9/014340
Inventors:
Philip A. Cole - New York NY
Ehab Khalil - Bronx NY
Assignee:
The Rockefeller University - New York NY
International Classification:
A61K 3170
C07H 1920
US Classification:
514 47
Abstract:
This invention is directed to a compound having the formula I. ##STR1## This invention is directed to a pharmaceutical composition comprising a compound which inhibits serotonin N-acetyltransferase having the formula I and a pharmaceutical acceptable carrier. The present invention relates to novel compounds and analogs which inhibit the serotonin N-acetyltransferase enzyme, and to processes for their preparation.

Arylmethoxy Isoindoline Derivatives And Compositions Comprising And Methods Of Using The Same

US Patent:
2022041, Dec 29, 2022
Filed:
Jul 18, 2022
Appl. No.:
17/867294
Inventors:
- Summit NJ, US
Roger Shen-Chu Chen - Edison NJ, US
George W. Muller - Rancho Santa Fe CA, US
Alexander L. Ruchelman - Cream Ridge NJ, US
Ehab M. Khalil - Yorktown VA, US
Weihong Zhang - Highland Park NJ, US
International Classification:
C07D 401/12
C07D 401/14
C07D 407/12
C07D 407/14
C07D 409/14
C07D 413/14
C07D 417/14
C07D 487/04
C07D 491/107
C07D 493/04
C07D 495/04
C07D 401/04
C07D 471/04
Abstract:
Provided are 4′-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

Arylmethoxy Isoindoline Derivatives And Compositions Comprising And Methods Of Using The Same

US Patent:
2020023, Jul 23, 2020
Filed:
Mar 31, 2020
Appl. No.:
16/836832
Inventors:
- Summit NJ, US
Roger Shen-Chu Chen - Edison NJ, US
George W. Muller - Rancho Santa Fe CA, US
Alexander L. Ruchelman - Cream Ridge NJ, US
Ehab M. Khalil - Yorktown VA, US
Weihong Zhang - Highland Park NJ, US
International Classification:
C07D 401/12
C07D 401/14
C07D 407/12
C07D 407/14
C07D 409/14
C07D 413/14
C07D 417/14
C07D 487/04
C07D 491/107
C07D 493/04
C07D 495/04
C07D 401/04
C07D 471/04
Abstract:
Provided are 4′-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

Arylmethoxy Isoindoline Derivatives And Compositions Comprising And Methods Of Using The Same

US Patent:
2018003, Feb 8, 2018
Filed:
Oct 17, 2017
Appl. No.:
15/786334
Inventors:
- Summit NJ, US
Roger Shen-Chu Chen - Edison NJ, US
George W. Muller - Rancho Santa Fe CA, US
Alexander L. Ruchelman - Cream Ridge NJ, US
Ehab M. Khalil - Yorktown VA, US
Weihong Zhang - Highland Park NJ, US
International Classification:
C07D 401/12
C07D 495/04
C07D 493/04
C07D 491/107
C07D 487/04
C07D 417/14
C07D 413/14
C07D 409/14
C07D 407/14
C07D 407/12
C07D 401/14
C07D 471/04
C07D 401/04
Abstract:
Provided are 4′-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

Arylmethoxy Isoindoline Derivatives And Compositions Comprising And Methods Of Using The Same

US Patent:
2016015, Jun 9, 2016
Filed:
Feb 10, 2016
Appl. No.:
15/040971
Inventors:
- Summit NJ, US
Roger Shen-Chu CHEN - Edison NJ, US
George W. MULLER - Rancho Santa Fe CA, US
Alexander L. RUCHELMAN - Cream Ridge NJ, US
Ehab M. KHALIL - Whitehouse Station NJ, US
Weihong ZHANG - Highland Park NJ, US
International Classification:
C07D 401/04
Abstract:
Provided are 4′-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

Arylmethoxy Isoindoline Derivatives And Compositions Comprising And Methods Of Using The Same

US Patent:
2016015, Jun 9, 2016
Filed:
Feb 10, 2016
Appl. No.:
15/040980
Inventors:
- Summit NJ, US
Roger Shen-Chu CHEN - Edison NJ, US
George W. MULLER - Rancho Santa Fe CA, US
Alexander L. RUCHELMAN - Cream Ridge NJ, US
Ehab M. KHALIL - Whitehouse Station NJ, US
Weihong ZHANG - Highland Park NJ, US
International Classification:
C07D 401/12
C07D 401/14
Abstract:
Provided are 4′-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.